Close

Mene Pangalos elected to the Fellowship of the Academy of Medical Sciences

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

AI in Specialty Chemicals is Advancing Innovation

The pharmaceutical specialty chemical industry is in the process...

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

IMED leader one of 48 new fellows recognised for the advancement of medical science in the UK

Each year the Academy of Medical Sciences elect a small number of UK scientists to their Fellowship in recognition of their contribution to the advancement of medical science. Potential Academy Fellows are nominated for election based on their excellence in medical research, their innovative application of scientific knowledge or for their service to healthcare.

Earlier today, it was announced that Mene Pangalos, Executive Vice President of our Innovative Medicines and Early Development Biotech Unit, has been elected as one of just 48 new Fellows – out of more than 350 nominations.

On hearing the news, Mene commented: “It’s a great honour to be elected as a Fellow of the Academy of Medical Sciences. I am looking forward to working with the Fellowship to drive greater connections between academia, industry and the NHS and to develop new ways to inspire the next generation of UK scientists.”

 

Latest stories

Related stories

Regulatory Changes in Europe Impact APIs and Excipients

There have been big changes in the pharmaceutical industry...

Reviving Old Drugs with Specialty Intermediates in Europe

Drug development in the European pharmaceutical industry is undergoing...

AI in Specialty Chemicals is Advancing Innovation

The pharmaceutical specialty chemical industry is in the process...

Revolutionizing Pharma Manufacturing with Biofermentation

Synthetic Chemistry and Integrated Biofermentation Transformational Pharmaceutical Manufacturing Combining biofermentation...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back